|
Risk factor
|
HR
|
95 % CI
|
p-value
|
|---|
|
Recipient male
|
1.18
|
0.79–1.76
|
0.417
|
|
Recipient age
|
1.01
|
1.00–1.03
|
0.034
|
|
Recipient body mass index
|
1.03
|
0.99–1.08
|
0.137
|
|
Donor male
|
1.13
|
0.79–1.63
|
0.491
|
|
Donor age
|
1.04
|
1.03–1.06
|
<0.001
|
|
CAD
|
1.65
|
1.18–2.30
|
0.003
|
|
No CMV
|
-
|
-
|
Ref.
|
|
CMV disease
|
2.03
|
1.39–2.95
|
<0.001
|
|
Asymptomatic CMV infection
|
1.63
|
1.07–2.46
|
0.022
|
|
Donor-related CAD
|
1.49
|
0.86–2.59
|
0.153
|
|
Cold ischemic time
|
1.00
|
0.99–1.00
|
0.518
|
|
AMR at first year
|
1.18
|
0.71–1.96
|
0.531
|
|
TRS
|
1.51
|
0.84–2.72
|
0.165
|
|
TRS ≥ 2R
|
2.07
|
0.87–4.93
|
0.099
|
|
Hypertension
|
1.39
|
0.89–2.18
|
0.146
|
|
Diabetes mellitus
|
1.05
|
0.85–1.30
|
0.646
|
|
Ex-smoker
|
1.23
|
0.87–1.76
|
0.245
|
|
CMV serology
| | | |
|
D−/R−
|
-
|
-
|
-
|
|
D−/R+
|
1.22
|
0.57–2.62
|
0.602
|
|
D+/R−
|
1.80
|
0.82–3.91
|
0.141
|
|
D+/R+
|
1.50
|
0.72–3.12
|
0.278
|
-
Ref reference category when calculating HR
